Modifications in drug adherence after switch to fixed-dose combination of perindopril/amlodipine in clinical practice. Results of a large-scale Italian experience. The amlodipine-perindopril in real settings (AMPERES) study

References

• Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016;37:2893-962
   PubMed Web of Science ®Google Scholar
• Agenzia Italiana del Farmaco (AIFA). L’uso dei farmaci in Italia—rapporto OsMed; 2015. Available at: http://www.agenziafarmaco.gov.it/sites/default/files/Rapporto_OsMed2015.pdf
   Google Scholar
• Crim MT, Yoon SS, Ortiz E, et al. National surveillance definitions for hypertension prevalence and control among adults. Circ Cardiovasc Qual Outcomes 2012;5:343-51
   PubMed Web of Science ®Google Scholar
• Volpe M, Tocci G, Trimarco B, et al. Blood pressure control in Italy: results of recent surveys on hypertension: J Hypertens 2007;25:1491-8
   PubMed Web of Science ®Google Scholar
• 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34:2159-219
   PubMed Web of Science ®Google Scholar
• Krause T, Lovibond K, Caulfield M, et al. Management of hypertension: summary of NICE guidance. BMJ 2011;343:d4891
   PubMed Web of Science ®Google Scholar
• Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press 2009;18:308-47
   PubMed Web of Science ®Google Scholar
• Lauffenburger JC, Landon JE, Fischer MA. Effect of combination therapy on adherence among US patients initiating therapy for hypertension: a cohort study. J Gen Intern Med [Internet]; 2017. Available at: http://link.springer.com/10.1007/s11606-016-3972-z. [Last accessed 6 March 2017]
   PubMed Web of Science ®Google Scholar
• World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003
   Google Scholar
• Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc 2011;86:304-14
   PubMed Web of Science ®Google Scholar
• Onder G, Marengoni A, Russo P, et al. Advanced age and medication prescription: more years, less medications? A nationwide report from the Italian Medicines Agency. J Am Med Dir Assoc 2016;17:168-72
   PubMed Web of Science ®Google Scholar
• Jesus NS de, Nogueira A da R, Pachu CO, et al. Blood pressure treatment adherence and control after participation in the ReHOT. Arq Bras Cardiol [Internet] 2016. Available at: http://www.gnresearch.org/doi/10.5935/abc.20160165. [Last accessed 6 March 2017]
   PubMed Web of Science ®Google Scholar
• Hussein MA, Chapman RH, Benner JS, et al. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees?: a non-randomized, observational, retrospective study. Am J Cardiovasc Drugs 2010;10:193-202
   PubMed Web of Science ®Google Scholar
• Wang TJ. Epidemiology of uncontrolled hypertension in the United States. Circulation 2005;112:1651-62
   PubMed Web of Science ®Google Scholar
• Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension 2010;55:399-407
   PubMed Web of Science ®Google Scholar
• Cheung BMY, Lau CP, Kumana CR. Combination therapy for hypertension. Hong Kong Med J Xianggang Yi Xue Za Zhi 2003;9:224-6
   PubMedGoogle Scholar
• Frank J. Managing hypertension using combination therapy. Am Fam Physician 2008;77:1279-86
   PubMed Web of Science ®Google Scholar
• AIFA Guideline for the classification and conduction of the observational studies on medicines. Available at: https://www.agenziafarmaco.gov.it/ricclin/sites/default/files/files_wysiwyg/files/CIRCULARS/Circular%2031st%20May%202010.pdf
   Google Scholar
• Catalan VS, LeLorier J. Predictors of long-term persistence on statins in a subsidized clinical population. Value Health 2000;3:417-26
   PubMedGoogle Scholar
• Mancia G, Sega R, Milesi C, et al. Blood-pressure control in the hypertensive population. Lancet 1997;349:454-7
   PubMed Web of Science ®Google Scholar
• Mancia G, Grassi G. Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens 2002;20:1461-4
   PubMed Web of Science ®Google Scholar
• Degli Esposti L, Valpiani G. Pharmacoeconomic burden of undertreating hypertension. PharmacoEconomics 2004;22:907-28
   PubMed Web of Science ®Google Scholar
• McCombs JS, Nichol MB, Newman CM, et al. The costs of interrupting antihypertensive drug therapy in a Medicaid population. Med Care 1994;32:214-26
   PubMed Web of Science ®Google Scholar
• Paramore LC, Halpern MT, Lapuerta P, et al. Impact of poorly controlled hypertension on healthcare resource utilization and cost. Am J Manag Care 2001;7:389-98
   PubMed Web of Science ®Google Scholar
• Degli Esposti L. Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients. Clin Outcomes Res 2011;3:47-54
   PubMedGoogle Scholar
• Mazzaglia G, Ambrosioni E, Alacqua M, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009;120:1598-605
   PubMed Web of Science ®Google Scholar
• Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ 1996;312:1215-18
   PubMed Web of Science ®Google Scholar
• Andrade SE, Kahler KH, Frech F, et al. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 2006;15:565-74
   PubMed Web of Science ®Google Scholar
• Fitz-Simon N, Bennett K, Feely J. A review of studies of adherence with antihypertensive drugs using prescription databases. Ther Clin Risk Manag 2005;1:93-106
   PubMedGoogle Scholar
• Hamdidouche I, Boutouyrie P. Is renal denervation an alternative or a complement to aldosterone antagonists in treatment of resistant hypertension? J Hypertens 2017;35:955-7
   PubMed Web of Science ®Google Scholar
• Tocci G, Muiesan ML, Parati G, et al. Trends in prevalence, awareness, treatment, and control of blood pressure recorded from 2004 to 2014 during World Hypertension Day in Italy. J Clin Hypertens 2016;18:551-6
   PubMed Web of Science ®Google Scholar
• Neutel JM. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients. Curr Med Res Opin 2008;24:2389-401
   PubMed Web of Science ®Google Scholar
• Zeng F, Patel BV, Andrews L, et al. Adherence and persistence of single-pill ARB/CCB combination therapy compared to multiple-pill ARB/CCB regimens. Curr Med Res Opin 2010;26:2877-87
   PubMed Web of Science ®Google Scholar
• Dahlöf B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005;366:895-906
   PubMed Web of Science ®Google Scholar
• The CAFE Investigators. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006;113:1213-25
   PubMed Web of Science ®Google Scholar
• Bangalore S, Kamalakkannan G, Parkar S, et al. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007;120:713-19
   PubMed Web of Science ®Google Scholar
• Gazzetta Ufficiale della Repubblica Italiana (Italian, trans. Official Gazette of the Italian Republic) Foglio delle inserzioni n.20 del 16-02-2017
   Google Scholar
• Vlachopoulos C, Grammatikou V, Kallistratos M, et al. Effectiveness of perindopril/amlodipine fixed dose combination in everyday clinical practice: results from the EMERALD study. Curr Med Res Opin 2016;32:1605-10
   PubMed Web of Science ®Google Scholar
• Kotovskaia IV, Villeval’de SV, Tigai ZG, et al. [Hypertensive patients’ adherence, motivation, and awareness during fixed-dose perindopril A and amlodipine combination treatment (results of the CONSTANTA trial)]. Ter Arkh 2015;87:64-9
   Web of Science ®Google Scholar
• Paneni F, Diaz Cañestro C, Libby P, et al. The aging cardiovascular system: understanding it at the cellular and clinical levels. J Am Coll Cardiol 2017;69:1952-67
   PubMed Web of Science ®Google Scholar